Advanced gastric cancer: Efficacy of anti-PD-1 antibodies plus multikinase inhibitors unaffected by liver metastasisJuly 31, 2022Gastrointestinal Cancer
Beta adrenergic blockade improves the prognosis of patients with CRCJuly 31, 2022Gastrointestinal Cancer
Hepatic arterial infusion-chemotherapy with FOLFIRINOX: A feasible treatment option for metastatic CRCJuly 31, 2022Gastrointestinal Cancer
Cardiovascular disease: The leading cause of noncancer death in CRCJuly 31, 2022Gastrointestinal Cancer
CRC: Colonoscopy offers a survival benefit over fecal immunochemical testJuly 31, 2022Gastrointestinal Cancer
Cytoreductive surgery + hyperthermic intraperitoneal chemotherapy confers survival benefit in CRC peritoneal metastasisJuly 31, 2022Gastrointestinal Cancer
Efficacy of colonoscopy for preventing CRC remains unaffected by locationJuly 31, 2022Gastrointestinal Cancer
FOLFIRI-bevacizumab tops FOLFIRI-aflibercept in treating metastatic CRC after FOLFOX-bevacizumab failureJuly 31, 2022Gastrointestinal Cancer
Stage II/III CRC: 3-month oxaliplatin with 6-month fluoropyrimidine, a promising adjuvant treatmentJuly 31, 2022Gastrointestinal Cancer
Link between Western diet, intestinal microbiota, and CRC: Findings from 2 U.S. cohort studiesJuly 31, 2022Gastrointestinal Cancer
Stage II colon cancer: ctDNA-guided approach reduces adjuvant chemotherapy use without compromising recurrence riskJuly 31, 2022Gastrointestinal Cancer
Oncology PracticeBarrett’s esophagus: AGA screening update ‘goes above and beyond’July 22, 2022GastroenterologyGastrointestinal CancerGI Oncology
Oncology PracticeLife-threatening adverse events in liver cancer less frequent with ICI therapyJuly 22, 2022Gastrointestinal Cancer
Oncology PracticeMarital status plays modest role in gastric cancer overall survivalJuly 18, 2022Gastrointestinal Cancer
